STRATEC Biomedical AG 

16.04.2015 18:19

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

1. Allianz Asset Management AG

Allianz SE, Munich, Germany, notified us pursuant to section 21 (1) in conjunction with section 24 of the German Securities Trading Act (WpHG) that the share of voting rights held by Allianz Asset Management AG, Munich, Germany, in STRATEC Biomedical AG, Birkenfeld, Germany, fell below the thresholds of 5 and 3% on April 7, 2015 and amounted to 0.29% (33,846 voting rights). These voting rights are attributed pursuant to section 22 (1) sentence 1 number 6 in conjunction with sentence 2 of the German Securities Trading Act (WpHG).


2. Allianz Global Investors GmbH

Allianz SE, Munich, Germany, notified us pursuant to section 21 (1) in conjunction with section 24 of the German Securities Trading Act (WpHG) that the share of voting rights held by Allianz Global Investors GmbH, Munich, Germany, in STRATEC Biomedical AG, Birkenfeld, Germany, fell below the thresholds of 5 and 3% on April 7, 2015 and amounted to 0.33% (39,430 voting rights). 0.30% (35,380 voting rights) are attributed pursuant to section 22 (1) sentence 1 number 6 of the German Securities Trading Act (WpHG).



16.04.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  

---